New drug trial aims to tame Parkinson's and MSA
NCT ID NCT06671938
First seen Oct 31, 2025 · Last updated May 12, 2026 · Updated 28 times
Summary
This study tests a new medicine called exidavnemab in people with mild to moderate Parkinson's disease or multiple system atrophy (MSA). The main goal is to check if the drug is safe and tolerable. Participants will receive either the drug or a placebo, and researchers will monitor side effects and how the drug moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centrum Medyczyne Neuromed Sp. z o.o.
Bydgoszcz, 85-163, Poland
-
Hospital Universitari General de Catalunya
Sant Cugat del Vallès, Barcelona, 08195, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona, 08035, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, Madrid, 28034, Spain
-
Hospital Universitario Virgen del Rocío
Seville, Andalusia, 41013, Spain
-
Krakowska Akademia Neurologii Sp. Z o.o
Krakow, 31-505, Poland
-
Policlínica Gipuzkoa
San Sebastián, 20014, Spain
Conditions
Explore the condition pages connected to this study.